Pharma giant Moderna (MRNA) is set to release its Q4 2024 results on February 14. MRNA stock has lost about 64% over the past ...

Cells in the body have to move around in order to do their jobs. During development, for instance, cells are distributed to ...

A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of ...

When Xiao Wang applied to faculty jobs, many of the institutions where she interviewed thought her research proposal - to ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

Nerve cells have amazing strategies to save energy and still perform the most important of their tasks. Researchers from the ...

A complex molecular machine, the spliceosome, ensures that the genetic information from the genome, after being transcribed ...

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

It's unclear how he will impact biotech stocks. Evaluate the expected performance of Moderna (MRNA) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom ...